Skip to main content
Robert Spiegel, MD, Oncology, Westfield, NJ

RobertJaySpiegelMD

Oncology Westfield, NJ

Hematologic Oncology, Neuro-Oncology

Physician

Dr. Spiegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spiegel's full profile

Already have an account?

  • Office

    400 elm st
    Westfield, NJ 07090

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1977 - 1979
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1974 - 1977
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1975
  • Yale University
    Yale UniversityB.A.

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of Directors
    Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of DirectorsAugust 4th, 2020
  • What Will Happen to Cyclacel Pharmaceuticals, Inc. (CYCCP) Next? The Stock Formed a Several Months Descending Triangle Pattern
    What Will Happen to Cyclacel Pharmaceuticals, Inc. (CYCCP) Next? The Stock Formed a Several Months Descending Triangle PatternMarch 12th, 2019
  • Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
    Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy CompanyDecember 8th, 2018
  • Join now to see all

Professional Memberships

Industry Relationships

  • Chief Medical Officer, Schering Plough1984 - 2011